X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
index medicus (7) 7
multiple myeloma (7) 7
bortezomib (5) 5
humans (4) 4
bone marrow (3) 3
hematology (3) 3
hematology, oncology and palliative medicine (3) 3
lenalidomide (3) 3
medicine (3) 3
proteasome inhibitors (3) 3
proteins (3) 3
cancer (2) 2
cell growth (2) 2
cell proliferation (2) 2
dexamethasone (2) 2
hemic and lymphatic diseases (2) 2
multiparameter flow-cytometry (2) 2
multiple myeloma - drug therapy (2) 2
oncology (2) 2
science (2) 2
stem-cell transplantation (2) 2
transplants & implants (2) 2
adult (1) 1
aged (1) 1
aged, 80 and over (1) 1
amyloidosis - drug therapy (1) 1
amyloidosis - metabolism (1) 1
amyloidosis - mortality (1) 1
analysis (1) 1
angiogenesis (1) 1
animals (1) 1
antineoplastic agents - adverse effects (1) 1
antineoplastic agents - pharmacology (1) 1
antineoplastic combined chemotherapy protocols - adverse effects (1) 1
antioxidants (1) 1
antioxidants - adverse effects (1) 1
antioxidants - pharmacology (1) 1
apoptosis (1) 1
article (1) 1
binding sites (1) 1
biomarkers (1) 1
biomarkers, tumor (1) 1
biopsy (1) 1
blood cells (1) 1
bone cancer (1) 1
bone diseases (1) 1
bone marrow cells (1) 1
bone marrow cells - pathology (1) 1
bone-marrow (1) 1
boronic acids - administration & dosage (1) 1
boronic acids - adverse effects (1) 1
boronic acids - therapeutic use (1) 1
bortezomib - adverse effects (1) 1
bortezomib - pharmacology (1) 1
brain natriuretic peptide (1) 1
cancer therapies (1) 1
cardiac involvement (1) 1
cardiotoxicity - etiology (1) 1
care and treatment (1) 1
carfilzomib (1) 1
caspase (1) 1
cell activation (1) 1
cell line, tumor (1) 1
cell survival (1) 1
chemokines (1) 1
chemotherapy (1) 1
chronic kidney disease-epidemiology collaboration (1) 1
chronic kidney failure (1) 1
chymotrypsin (1) 1
circulating plasma-cells (1) 1
combination (1) 1
complications and side effects (1) 1
consensus (1) 1
cxcl10 protein (1) 1
cyclophosphamide (1) 1
cytokines (1) 1
daratumumab (1) 1
dexamethasone - administration & dosage (1) 1
dexamethasone - therapeutic use (1) 1
diagnosis (1) 1
diseases (1) 1
dose dexamethasone (1) 1
dose-response relationship, drug (1) 1
drosophila - drug effects (1) 1
drug administration schedule (1) 1
drug dosages (1) 1
drug therapy (1) 1
drug therapy, combination (1) 1
early intervention (1) 1
education (1) 1
efficacy (1) 1
egfr (1) 1
elotuzumab (1) 1
endoplasmic reticulum (1) 1
epidemiology (1) 1
epidermal growth factor receptors (1) 1
equation (1) 1
er stress (1) 1
expression (1) 1
extramedullary disease (1) 1
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Lancet Oncology, The, ISSN 1470-2045, 2016, Volume 17, Issue 8, pp. e328 - e346
Journal Article
Lancet Oncology, The, ISSN 1470-2045, 2014, Volume 15, Issue 12, pp. e538 - e548
Journal Article
Journal Article
American Journal of Hematology, ISSN 0361-8609, 04/2015, Volume 90, Issue 4, pp. E60 - E65
Journal Article
European Journal of Haematology, ISSN 0902-4441, 01/2018, Volume 100, Issue 1, pp. 10 - 19
Objectives This randomized, international, multicenter, open‐label phase III study investigated the effects of experimental retreatment with subcutaneous... 
dexamethasone | relapsed | bortezomib | Myeloma | retreatment | DARATUMUMAB | EFFICACY | SAFETY | CYCLOPHOSPHAMIDE | PLUS BORTEZOMIB | COMBINATION | DOSE DEXAMETHASONE | LENALIDOMIDE | PERIPHERAL NEUROPATHY | HEMATOLOGY | MELPHALAN | Complications and side effects | Care and treatment | Relapse | Bortezomib | Dexamethasone | Multiple myeloma | Diseases | Thrombocytopenia
Journal Article
Journal Article
Oncology Research and Treatment, ISSN 2296-5270, 06/2010, Volume 33, Issue 6, pp. 340 - 341
Journal Article
Oncology Research and Treatment, ISSN 2296-5270, 06/2010, Volume 33, Issue 6, pp. 338 - 338
Journal Article
02/2007, Volume 78, Issue 2, 2
Book Review
No results were found for your search.

Cannot display more than 1000 results, please narrow the terms of your search.